国产帕利哌酮缓释片治疗稳定期精神分裂症的疗效与安全性OACSTPCD
Efficacy and safety of domestic Paliperidone extended-release tablets in the treatment of stable schizophrenia
目的 探讨国产帕利哌酮缓释片替代原研帕利哌酮缓释片治疗稳定期精神分裂症的疗效和安全性.方法 收集2021年6月至2022年6月于山东省戴庄医院门诊就诊或住院且单一使用原研帕利哌酮缓释片治疗2个月及以上的精神分裂症患者65例,按随机数字表法分为国产组(33例)和原研组(32例);国产组患者换用相同剂量国产帕利哌酮缓释片治疗2个月,原研组患者继续使用原研药原剂量治疗2个月.分别于入组时和入组治疗1周末、1个月末和2个月末分别进行阳性和阴性症状量表(P…查看全部>>
OBJECTIVE To investigate the efficacy and safety of domestic Paliperidone extended-release tablets as a substitute for original Paliperidone extended-release tablets in the treatment of stable schizophrenia.METHODS A total of 65 patients with schizophrenia,who were treated with single original Paliperidone extended-release release tablets for 2 months or more in the outpatient or inpatient department of Shandong Daizhuang Hospital from June 2021 to June 2022…查看全部>>
李秀英;陈莹;陈宏
山东省戴庄医院药学部,山东 济宁 272051山东省戴庄医院精神科,山东济宁 272051山东省戴庄医院精神科,山东济宁 272051
药学
帕利哌酮缓释片精神分裂症国产制剂原研制剂疗效安全性
Paliperidone extended-release tabletsschizo-phreniadomestic preparationoriginal preparationefficacysafety
《中国药房》 2023 (24)
3051-3054,4
评论